Empiric antimicrobial selection

Empiric Principles - The Educated Guess

• Identify Likely Pathogens: Base decision on infection site, patient demographics, and initial Gram stain results.
• Assess Host Factors: Consider age, immune status (e.g., neutropenia), comorbidities (diabetes), and recent exposures (hospitalization, travel).
• Use Local Antibiograms: Tail therapy to local resistance patterns to ↑ efficacy.
• De-escalate Promptly: Start broad, then narrow spectrum based on culture & sensitivity results (typically 48-72 hrs) to ↓ resistance and toxicity.

⭐ High risk for Clostridioides difficile colitis exists with broad-spectrum coverage (e.g., clindamycin, fluoroquinolones).

Common Syndromes - The Usual Suspects

• Meningitis
  • Neonate (<1 mo): GBS, E. coli, Listeria → Ampicillin + Gentamicin/Cefotaxime
  • Child/Adult (1 mo - 50 yr): S. pneumo, N. meningitidis → Ceftriaxone + Vancomycin
  • Older Adult (>50 yr): S. pneumo, N. meningitidis, Listeria → Ceftriaxone + Vancomycin + Ampicillin
• Community-Acquired Pneumonia (CAP)
  • Outpatient: S. pneumo, Atypicals → Doxycycline or Macrolide
  • Inpatient (non-ICU): S. pneumo, H. flu, Atypicals → Ceftriaxone + Azithromycin/Doxycycline
• Hospital-Acquired Pneumonia (HAP)
  • Pseudomonas, MRSA, GNRs → Piperacillin-tazobactam + Vancomycin
• Urinary Tract Infection (UTI)
  • Uncomplicated: E. coli → TMP-SMX, Nitrofurantoin
• Skin/Soft Tissue
  • Cellulitis (non-purulent): Strep, MSSA → Cephalexin
  • Abscess (purulent): MRSA → I&D; consider TMP-SMX

⭐ For suspected meningitis, add Ampicillin to cover Listeria monocytogenes in patients at the extremes of age (<1 month or >50 years).

The Drug Arsenal - Choosing Your Weapon

Empiric therapy is an educated guess. Base your choice on clinical data and local resistance patterns before culture results are back. Always obtain cultures before the first dose!

• Identify the Culprit: Gram stain, infection site (e.g., lung, UTI), and patient history narrow the list of likely pathogens.
• Assess the Host: Consider allergies (e.g., penicillin), renal/hepatic function for dose adjustments, age, and pregnancy status.
• Know Your Battlefield: Use the local hospital antibiogram to guide choices against resistant organisms.

⭐ For suspected meningitis in adults, empiric therapy typically combines Ceftriaxone (for S. pneumoniae, N. meningitidis) + Vancomycin (for resistant pneumococci). Add Ampicillin if Listeria monocytogenes is suspected (e.g., age >50 or immunocompromised).

Special Ops - MRSA & Pseudomonas

• MRSA Coverage (Gram-Positive)
  • IV: Vancomycin, Daptomycin, Linezolid, Ceftaroline.
  • Oral (CA-MRSA): Trimethoprim-Sulfamethoxazole (TMP-SMX), Clindamycin, Doxycycline.
• Pseudomonas aeruginosa Coverage (Gram-Negative)
  • Beta-Lactams: Piperacillin-Tazobactam, Cefepime, Ceftazidime, Meropenem, Imipenem, Aztreonam.
  • Others: Ciprofloxacin, Levofloxacin, Aminoglycosides (e.g., Gentamicin).

⭐ Daptomycin is ineffective for MRSA pneumonia as it is inactivated by pulmonary surfactant. Always choose an alternative like Vancomycin or Linezolid.

• Empiric therapy is initiated before identifying the exact pathogen, based on the most likely causative organisms and site of infection.
• Selection is guided by local resistance patterns (antibiograms), patient risk factors (e.g., immunosuppression, recent hospitalization), and the severity of illness.
• For life-threatening infections like sepsis or bacterial meningitis, administer broad-spectrum coverage immediately after obtaining cultures.
• Always obtain appropriate cultures before starting antibiotics, but do not delay therapy.
• De-escalate to a narrower-spectrum agent once culture and sensitivity results are available.